[19] and the Mastermind (Mam)/Lag-3 co-activator [20] . This complex binds specific regulatory DNA sequences and activates the expression of CSL/Notch target genes. In the absence of NICD, CSL can recruit repressor complexes to the cis-regulatory region of the CSL/Notch target genes. Therefore, activation of Notch triggers a switch from repression to activation (Figure 2 ) [19, 21, 22] . Notably, endogenous NICD has not been detected in the nucleus of signal-receiving cells. This has led to the suggestion that NICD acts at a very low concentration, below immuno-detection threshold [16] .
Properties of Signaling via Regulated Intramembrane Proteolysis
Signaling by bi-functional proteins that, like Notch, integrate ligand binding at the cell surface and transcriptional regulation in the nucleus involves regulated intramembrane proteolysis (RIP) [23] . Signaling via RIP is an unusual mode of signal transduction used by a number of unrelated membrane proteins, such as SREBP, APP and N-Cadherin [23, 24] . This mode of signaling has several interesting features: First, proteolytic cleavage is irreversible and, as the cleavage physically dissociates the ligand binding unit from the intracellular signaling unit, each receptor molecule can only signal once. Thus, intensity and duration of signaling cannot be regulated by receptor desensitization. Second, signaling is direct and is not relayed by secondary messenger molecules. This property clearly limits the possibilities for signal amplification and cross-talk between different signaling pathways. Third, receptor processing releases extracellular by-products that may either have novel signaling activities or act to downregulate signaling, for instance via titrating the ligands.
These properties have obvious implications on how signaling by Notch may be inhibited or buffered in space and time. The dramatic consequences caused by the forced expression of NICD indicate that Notch receptor signaling activity must be tightly regulated; for instance, expression of an activated version of human Notch1 in T-cells causes acute lymphoblastoma [25] and ectopic expression of NICD blocks early neurogenesis in fly and vertebrate embryos [26] [27] [28] . Furthermore, whereas the timing and positioning of Notch activation obviously depends on the presence of its activating ligands, the pattern of Notch activity is, Review R130 Receptor endocytosis may also positively regulate signal transduction. For instance, endocytosis may bring active receptors to a specific intracellular compartment where they associate with their signal transduction machinery. Analysis of the Drosophila shibire (shi) gene, which encodes a GTPase involved in pinching off endocytic vesicles from the plasma membrane, has revealed that endocytosis plays a positive role in Notch receptor signaling. When grown at restrictive temperatures, temperature sensitive shi mutants exhibit a Notch-like phenotype. Results from clonal analysis further suggested that shi activity is required in both the signal-sending and the signal-receiving cells [74] . The basis for the requirement of shi-dependent endocytosis in the signalreceiving cell is not understood. As NICD, but not fulllength Notch, is active in a shi mutant background [74] , one hypothesis is that endocytosis may transfer NEXT from the plasma membrane to an intracellular compartment, which contains the γ γ-secretase activity. Third, the stability of NICD has recently been suggested to be regulated by phosphorylation. GSK3β β has been shown to phosphorylate NICD in vitro and inhibition of GSK3β β decreased the stability of NICD and reduced Notch receptor signaling [93] . Thus, GSK3β β-mediated phosphorylation appears to stabilize NICD and potentiate its activity.
Regulation of Notch Signaling by Numb and Sanpodo
Finally, cross-regulation by other signaling pathways may target Notch regulators. For instance, mouse Numb has been shown to be down-regulated by two E3 ubiquitin ligases, Sina and LNX [94, 95] , thus raising the possibility that Numb stability may be signal-regulated.
Whereas our understanding of signal integration between Notch and other signal transduction pathways is still very preliminary, many of the regulatory steps discussed in this review may be subject to cross-regulatory interactions. Further insights into cross-talk between Notch and other signaling pathways will certainly arise from global proteomic and functional genomic approaches that are currently under way.
CSL-Independent Signaling
So far, I have only discussed the canonical CSL-dependent pathway in which the key active signaling molecule is NICD and the output is transcription. However, studies in both invertebrate and vertebrate species have also pointed toward CSL-independent signaling activities (see [96] 
Conclusions and Perspectives
In this review, I have highlighted the importance of keeping Notch activity under tight control and I have emphasized the diversity of the mechanisms that, despite the apparent simplicity and directness inherent in signaling via RIP, are involved in the regulation of Notch activity. Strikingly, one of the most critical steps in Notch receptor signaling, the S3 cleavage of NEXT, is apparently not subject to regulation. While there is yet no evidence that the γ γ-secretase activity is subject to developmental regulation, recent studies indicate that the γ γ-secretase complex is assembled and activated in a stepwise manner, opening the way for possible regulation [101] . Finally, the study of Notch regulation has potential implications for our understanding of other important physiological processes that depend on RIP signaling. This can be illustrated by the binding of the Notch inhibitor Numb to the intracellular domain of APP [102] . Future analysis of the cell biology of Notch receptor signaling may therefore shed light on fundamental cellular regulatory processes.
